<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04609124</url>
  </required_header>
  <id_info>
    <org_study_id>DASH1001</org_study_id>
    <nct_id>NCT04609124</nct_id>
  </id_info>
  <brief_title>Effect of Intravenous Metochlopramide Prophylaxis on Gastric Volume</brief_title>
  <official_title>the Effect of Intravenous Metochlopramide Prophylaxis on Gastric Volume and Antral Cross Sectional Area in Patients Awaiting for Caesarean Section :a Randomized Double Blind Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastric fluid volume and pH in patients undergoing cesarean section are essential&#xD;
      considerations for general anesthesia (GA). Increased gastric volume and low pH of gastric&#xD;
      contents could predispose the risk of aspiration pneumonitis. The present study explored the&#xD;
      research question &quot;whether prophylaxis with intravenous metoclopramide significantly reduces&#xD;
      gastric volume and antral cross-sectional area in patients awaiting cesarean section under GA&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since regional anaesthesia has largely replaced general anaesthesia, the risk of aspiration&#xD;
      pneumonitis during caesarean sections has significantly decreased. Nevertheless, prophylaxis&#xD;
      against gastric aspiration is still important in patients in whom regional anaesthesia is&#xD;
      contraindicated or in whom general anaesthesia has to be administered (for example; during&#xD;
      emergency caesarean delivery). The administration of intravenous anaesthetics reduces the&#xD;
      level of consciousness of a patient that compromises the protective reflexes of the upper&#xD;
      airways. Moreover, a high level of sedation also reduces the tone of the LES (lower&#xD;
      oesophageal sphincter). Both these situations predispose the risk of aspiration pneumonia in&#xD;
      patients awaiting surgical interventions in supine position under general anaesthesia.&#xD;
&#xD;
      The risk of aspiration increases in outpatients if the volume of the gastric contents&#xD;
      increases beyond 25 ml and its pH falls below 2.5. However, the risk of aspiration&#xD;
      significantly decreases in &quot;fasted&quot; outpatients. Since most patients awaiting elective&#xD;
      surgery remains fasted, routine prophylaxis for preventing aspiration pneumonitis is not&#xD;
      recommended anymore.&#xD;
&#xD;
      the administration of intravenous metoclopramide and cimetidine across patients (n=20)&#xD;
      awaiting laparoscopic gynaecological surgery significantly increased the pH of the gastric&#xD;
      contents in the intervention group compared to their control counterparts (6.1 versus 2.7,&#xD;
      p&lt;0.05). The mean aspirated volumes were also significantly lower in the intervention group&#xD;
      compared to their age-matched controls (6.9ml versus 15.3ml, p&lt;0.05). Hong (2006) further&#xD;
      showed that the percentage of individuals with high-risk gastric volume (&gt;25 ml) and low pH&#xD;
      (&lt;2.5) was higher in individuals who did not receive intravenous metoclopramide and&#xD;
      cimetidine prior to surgery compared to their counterparts who received such interventions&#xD;
      (20% versus 5%, p&lt;0.05) .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 24, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>effect of S intravenous metoclopramide prophylaxis on gastric volume</measure>
    <time_frame>2 hours</time_frame>
    <description>antral cross section will be measured using ultrasound machine before and after metoclopramide injection</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Metochloprmide Prophylaxis</condition>
  <arm_group>
    <arm_group_label>Intervention group:</arm_group_label>
    <description>Patients (n=35) fasting for 8 hours and received 10 mg metoclopramide intravenously diluted in 10 mL saline 0.9%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group:</arm_group_label>
    <description>Patients (n=35) fasting for 8 hours and received intravenous 10 mL saline 0.9% as placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Abdominal ultrasound evaluation of antral area</intervention_name>
    <description>ultrasound assessment of antral cross sectional area</description>
    <arm_group_label>Control group:</arm_group_label>
    <arm_group_label>Intervention group:</arm_group_label>
    <other_name>Nausea and vomiting episodes</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        pregnant females&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  pregnant women belonging to the age range between 22 to 38 years and who provided&#xD;
             informed consent to participate.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  a neurological and psychological disorders&#xD;
&#xD;
          -  renal or hepatic diseases&#xD;
&#xD;
          -  chronic gastroesophageal reflux diseases&#xD;
&#xD;
          -  refusal to consent&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>female</gender_description>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>esam hamed, MD</last_name>
    <phone>01000440773</phone>
    <email>ehamed@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assiut University Hospitals</name>
      <address>
        <city>Assiut</city>
        <zip>71515</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Esam M Hamed, MD</last_name>
      <phone>01002228905</phone>
      <email>ehamed@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Mohamed Fathy, MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 3, 2020</study_first_submitted>
  <study_first_submitted_qc>October 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2020</study_first_posted>
  <last_update_submitted>October 23, 2020</last_update_submitted>
  <last_update_submitted_qc>October 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Esam Hamed</investigator_full_name>
    <investigator_title>Consultant</investigator_title>
  </responsible_party>
  <keyword>metoclopramide</keyword>
  <keyword>cesarean section</keyword>
  <keyword>ultrasound</keyword>
  <keyword>gastric volume</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>only the outcome of the study no personal identity will be revealed</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

